Literature DB >> 9529105

Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization.

G Hajishengallis1, M W Russell, S M Michalek.   

Abstract

Previous studies have identified an N-terminal saliva-binding region (SBR) on Streptococcus mutans surface antigen I/II (AgI/II) and suggested its importance in the initial adherence of S. mutans to saliva-coated tooth surfaces and subsequent development of dental caries. In this study, we compared the SBR with a C-terminal structural region of AgI/II (AgII) in their abilities to induce protective immunity against caries in rats. When SBR, AgII, or the whole AgI/II molecule was administered intranasally as a conjugate with the B subunit of cholera toxin (CT), in the presence of CT adjuvant, substantial levels of salivary immunoglobulin A anti-AgI/II antibodies were induced. Evaluation of caries activity showed that the SBR, though not as protective as the parent molecule, was superior to AgII and thus can be further considered as a component in a multivalent caries vaccine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529105      PMCID: PMC108112     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  Immunization against dental caries.

Authors:  M W Russell
Journal:  Curr Opin Dent       Date:  1992-09

Review 2.  Development and outlook for a caries vaccine.

Authors:  S M Michalek; N K Childers
Journal:  Crit Rev Oral Biol Med       Date:  1990

3.  Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.

Authors:  H Y Wu; M W Russell
Journal:  Vaccine       Date:  1998 Jan-Feb       Impact factor: 3.641

4.  Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.

Authors:  M T Dertzbaugh; C O Elson
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

5.  Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease-resistant component.

Authors:  M W Russell; L A Bergmeier; E D Zanders; T Lehner
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

6.  Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage.

Authors:  G Hajishengallis; E Nikolova; M W Russell
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

7.  Identification of a salivary agglutinin-binding domain within cell surface adhesin P1 of Streptococcus mutans.

Authors:  P J Crowley; L J Brady; D A Piacentini; A S Bleiweis
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.

Authors:  J Katz; C C Harmon; G P Buckner; G J Richardson; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Immunization with purified protein antigens from Streptococcus mutans against dental caries in rhesus monkeys.

Authors:  T Lehner; M W Russell; J Caldwell; R Smith
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

10.  Comparison of extracellular protein profiles of seven serotypes of mutans streptococci grown under controlled conditions.

Authors:  L N Hardy; K W Knox; R A Brown; A J Wicken; R J Fitzgerald
Journal:  J Gen Microbiol       Date:  1986-05
View more
  21 in total

1.  Intranasal immunization against dental caries with a Streptococcus mutans-enriched fimbrial preparation.

Authors:  M Fontana; A J Dunipace; G K Stookey; R L Gregory
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Flagellin-rPAc vaccine inhibits biofilm formation but not proliferation of S. mutans.

Authors:  Ying Sun; Yi Yang; Dihan Zhou; Yuan Cao; Jie Yu; Bali Zhao; Maohua Zhong; Yaoming Li; Jingyi Yang; Huimin Yan
Journal:  Hum Vaccin Immunother       Date:  2016-07-08       Impact factor: 3.452

3.  Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.

Authors:  X Shen; T Lagergård; Y Yang; M Lindblad; M Fredriksson; J Holmgren
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.

Authors:  E Harokopakis; G Hajishengallis; S M Michalek
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activation.

Authors:  Qingan Xu; Jenny Katz; Ping Zhang; Amit R Ashtekar; Dalia E Gaddis; Mingwen Fan; Suzanne M Michalek
Journal:  Infect Immun       Date:  2011-07-11       Impact factor: 3.441

6.  Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.

Authors:  Ping Zhang; Christina Jespersgaard; Leticia Lamberty-Mallory; Jannet Katz; Yan Huang; George Hajishengallis; Suzanne M Michalek
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.

Authors:  Y Huang; G Hajishengallis; S M Michalek
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1.

Authors:  Nikki R Rhodin; Marloes L J A Van Tilburg; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A.

Authors:  Nikki R Rhodin; Jenny M Cutalo; Kenneth B Tomer; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry.

Authors:  Weiwei Zhao; Hans Minderman; Michael W Russell
Journal:  Clin Vaccine Immunol       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.